Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Oldenburg, J; Mahlangu, JN; Kim, B; Schmitt, C; Callaghan, MU; Young, G; Santagostino, E; Kruse-Jarres, R; Negrier, C; Kessler, C; Valente, N; Asikanius, E; Levy, GG; Windyga, J; Shima, M

Oldenburg, J (reprint author), Univ Klinikum Bonn, Inst Expt Hematol & Transfus Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.

NEW ENGLAND JOURNAL OF MEDICINE, 2017; 377 (9): 809

Abstract

BACKGROUND Emicizumab (ACE910) bridges activated factor IX and factor X to restore the function of activated factor VIII, which is deficient in person......

Full Text Link